Journal of General Internal Medicine

, Volume 25, Issue 1, pp 79–83

Limiting the Influence of Pharmaceutical Industry Gifts on Physicians: Self-Regulation or Government Intervention?

Authors

    • Department of MedicineUniversity of Pennsylvania
    • Leonard Davis Institute of Health EconomicsUniversity of Pennsylvania
Health Policy

DOI: 10.1007/s11606-009-1016-7

Cite this article as:
Grande, D. J GEN INTERN MED (2010) 25: 79. doi:10.1007/s11606-009-1016-7

Abstract

Concerns over the influence of pharmaceutical gifts on physicians have surged in recent years. This has prompted wide ranging legislative proposals in numerous states and in the federal government as well as stepped up efforts at self-regulation by the pharmaceutical industry and the medical profession. Policymakers face the decision of whether to defer to self-regulation or support government intervention. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession. The author examines and critiques the wide ranging legislative strategies pursued to limit the influence of pharmaceutical gifts on physicians and concludes with suggestions for policymakers and the profession to limit influence and preserve public trust.

KEY WORDS

medical professionalismpharmaceutical marketingconflicts of interest

Copyright information

© Society of General Internal Medicine 2009